Transplant center directory

The Blood and Marrow Transplant Program at the Georgia Cancer Center is comprised of a 12-bed inpatient unit. The program is accredited through the Foundation for the Accreditation of Cellular Therapy (FACT). This center has been performing autologous transplants since 1997, allogeneic transplants since 2000, haploidentical transplants since 2014, cord transplants since 2015, and has been an NMDP transplant center since February 2010. CART therapy since 2021. Disease treated are aplastic anemia, amyloidosis, hodgkin's lymphoma, leukemias, multiple myeloma, myelodysplastic syndrome, myelofibroisis, and non-hodgkins lymphoma to name a few.

This center has been performing allogeneic transplants since 2000 and has been an NMDP/Be The Match transplant center since February 2010.

This center's actual 1-year survival results are similar to the expected rate for this center.

The survival information we have for this center includes ONLY:

1. Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2019, 2020, 2021, and
2. Who had their transplant at a U.S. transplant center, and
3. Who had follow-up information provided by the transplant center for analysis

For this center, we have survival information for 64 patients.

The actual 1-year survival of these patients is 73.4%.

Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 56.9% and 78.5%.

For help with understanding these statistics, please see Understanding Transplant Outcomes.

For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.

All diseases

Number of transplants by age reported from January 1, 2021 to December 31st, 2022 (includes marrow, PBSC and cord blood)

Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.